Shanghai Pharmaceuticals Holding Co Ltd (SHPMY)
7.915
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Shanghai Pharmaceuticals Gross Profit Margin (Quarterly): 11.44% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.44% |
| December 31, 2023 | 11.73% |
| September 30, 2023 | 10.63% |
| June 30, 2023 | 12.69% |
| March 31, 2023 | 13.04% |
| December 31, 2022 | 13.61% |
| September 30, 2022 | 12.16% |
| June 30, 2022 | 14.05% |
| March 31, 2022 | 12.88% |
| December 31, 2021 | 12.45% |
| September 30, 2021 | 13.81% |
| June 30, 2021 | 13.16% |
| March 31, 2021 | 13.48% |
| December 31, 2020 | 12.72% |
| September 30, 2020 | 13.28% |
| June 30, 2020 | 14.68% |
| March 31, 2020 | 15.46% |
| December 31, 2019 | 15.54% |
| September 30, 2019 | 13.30% |
| June 30, 2019 | 14.35% |
| March 31, 2019 | 14.35% |
| December 31, 2018 | 14.34% |
| September 30, 2018 | 13.58% |
| June 30, 2018 | 13.90% |
| March 31, 2018 | 15.00% |
| Date | Value |
|---|---|
| December 31, 2017 | 13.66% |
| September 30, 2017 | 12.39% |
| June 30, 2017 | 12.73% |
| March 31, 2017 | 12.38% |
| December 31, 2016 | 11.44% |
| September 30, 2016 | 11.55% |
| June 30, 2016 | 12.06% |
| March 31, 2016 | 12.10% |
| December 31, 2015 | 12.47% |
| September 30, 2015 | 11.45% |
| June 30, 2015 | 12.08% |
| March 31, 2015 | 12.59% |
| December 31, 2014 | 12.59% |
| September 30, 2014 | 11.52% |
| June 30, 2014 | 12.55% |
| March 31, 2014 | 12.81% |
| December 31, 2013 | 13.34% |
| September 30, 2013 | 12.50% |
| June 30, 2013 | 13.17% |
| March 31, 2013 | 13.35% |
| December 31, 2012 | 14.21% |
| September 30, 2012 | 12.79% |
| June 30, 2012 | 13.62% |
| March 31, 2012 | 13.98% |
| December 31, 2011 | 14.55% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
10.63%
Minimum
Sep 2023
15.54%
Maximum
Dec 2019
13.22%
Average
13.22%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 59.05% |
| Zai Lab Ltd | 61.42% |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.72% |
| Return on Assets | 1.78% |
| Return on Invested Capital | 3.02% |
| Profit Margin (Quarterly) | 2.20% |
| Operating Margin (Quarterly) | 3.85% |
| Return on Net Operating Assets | 2.39% |